HIV medicine academy opposes price increase for Norvir

LETTER — Posted April 12, 2004

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

Regarding "Doctors protest 400% price hike in HIV medication," (Article, March 8): Your article states that: "Abbott spokeswoman Ann Fahey-Widman said company representatives met with doctors, including members of the HIV Medicine Assn. and the American Academy of HIV Medicine; patients; and patient advocates about the matter. Afterward, the company decided to leave the drug [Norvir] pricing at the current level in most cases."

Our concern is that the above is worded so that it implies that Abbott left the price increase in place with the agreement of the academy and other parties. In fact, the academy does not agree with the price increase even with the recent steps taken by Abbott listed above.

The academy has taken a strong stand against the Norvir price increase. On Jan. 2, the academy formally responded to this matter with a strong letter to the Abbott CEO rebutting some of the company's claims, expressing academy members' extreme concern, and urging Abbott to significantly reduce the price increase. In addition, the academy has made the decision to not request funding from Abbott Laboratories for additional projects.

Howard Grossman, MD, chair, New York/New Jersey Chapter; board chair, Public Policy Committee, American Academy of HIV Medicine Los Angeles

Note: This item originally appeared at http://www.ama-assn.org/amednews/2004/04/12/edlt0412.htm.

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn